Daniel Ollendorf, PhD, MPH
Chief Scientific Officer and Director of Health Technology Assessment Methods and Engagement
Dan Ollendorf is ICER’s Chief Scientific Officer and Director of Health Technology Assessment (HTA) Methods and Engagement, with responsibility for managing the organization’s internal health economics capacity and program of external collaboration, as well as collaboration with international HTA bodies and other stakeholders on key process and methods topics.
From 2007-2018, Dr. Ollendorf was Chief Scientific Officer for ICER, where he oversaw the broader HTA process and managed relationships with multiple stakeholders and research collaborators. From 2018-2023, Dr. Ollendorf served as the Director of Value Measurement & Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center, where he focused on value assessment methods, drug pricing policy, and building international capacity for and interest in HTA. In addition to his current role at ICER, Dr. Ollendorf maintains a faculty appointment at CEVR and continues to teach in the Center’s graduate certificate program as well as participate in ongoing research.
Dr. Ollendorf also serves as a non-resident Fellow in Global Health at the Center for Global Development and is the current Chair of the Health Technology Assessment International (HTAi) Global Policy Forum. He received his PhD in Clinical Epidemiology from the University of Amsterdam, and an MPH in Health Policy & Management/Epidemiology from Boston University.
